| Ticker Details |
|
Galecto, Inc. Common Stock
|
| IPO Date: |
October 29, 2020 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$1.73B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.32 | 4.24%
|
| Avg Daily Range (30 D): |
$0.07 | 0.24%
|
| Avg Daily Range (90 D): |
$1.32 | 5.30%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.35M |
| Avg Daily Volume (30 D): |
M |
| Avg Daily Volume (90 D): |
.09M |
| Trade Size |
| Avg Trade Size (Sh.): |
88 |
| Avg Trade Size (Sh.) (30 D): |
38 |
| Avg Trade Size (Sh.) (90 D): |
98 |
| Institutional Trades |
| Total Institutional Trades: |
65 |
| Avg Institutional Trade: |
$2.1M |
| Avg Institutional Trade (30 D): |
$2.33M |
| Avg Institutional Trade (90 D): |
$3M |
| Avg Institutional Trade Volume: |
.06M |
| Avg Institutional Trades (Per Day): |
3 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.78M |
| Avg Closing Trade (30 D): |
$.56M |
| Avg Closing Trade (90 D): |
$4.23M |
| Avg Closing Volume: |
87.3K |
|
|
| Financials |
| |
TTM |
Q4 2025 |
FY 2025 |
|
Basic EPS
|
$5.28
|
$10.86
|
$3.98
|
|
Diluted EPS
|
$5.28
|
$10.86
|
$3.98
|
|
Revenue
|
$4.16M
|
$1M
|
$1.17M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$-235.02M
|
$-200.74M
|
$-209.84M
|
|
Operating Income / Loss
|
$-239.08M
|
$-201.7M
|
$-210.87M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$245.73M
|
$250.02M
|
$243.45M
|
|
PE Ratio
|
|
|
|
|
|
|